Evidence map›Paper›PMID 41061279›Full record

ReviewArchivos de cardiologia de Mexico2025

Group 4 pulmonary hypertension due to choriocarcinoma after molar pregnancy: case report and review.

Ángel A Montañez-Aguirre, Jessica M Flores-Guerra, Santiago Obregón-Rosas, Alberto Aranda-Fraustro, Víctor A Quiroz Martínez-Martínez, Karina Del Valle Zamora

Abstract readCase ReportsReview
In one paragraph

Review in Archivos de cardiologia de Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ángel A Montañez-Aguirre18th Floor Hospitalization, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Jessica M Flores-Guerra18th Floor Hospitalization, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Santiago Obregón-RosasSubdirectorate of Teaching Coordination, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Alberto Aranda-FraustroDepartment of Pathology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Víctor A Quiroz Martínez-Martínez18th Floor Hospitalization, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Karina Del Valle Zamora18th Floor Hospitalization, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 46-year-old Mexican woman developed type 4 pulmonary hypertension (PH) due to tumor embolism from choriocarcinoma (CC), which is an uncommon presentation of this malignancy. She presented with precordial pain, dyspnea, and rapid functional decline. Imaging revealed obstructive thrombi in the pulmonary arteries, initially suggestive of operable chronic thromboembolic PH (CTEPH). A bilateral subsegmental pulmonary thromboendarterectomy was performed, the standard treatment for CTEPH, aimed at removing obstructive material and restoring hemodynamic stability. However, histopathological examination of the surgical specimens showed malignant cells positive for human chorionic gonadotropin, confirming CC as the source of tumor emboli and leading to reclassification of her condition as type 4.2.2 PH. The patient died intraoperatively due to severe airway bleeding and inability to wean from cardiopulmonary bypass.

Indexed as

ChoriocarcinomaHydatidiform MoleHypertension, PulmonaryUterine NeoplasmsFatal OutcomeFemaleHumansMiddle AgedPregnancyChoriocarcinomaPulmonary embolismPulmonary hypertensionThromboembolismThromboendarterectomy

Identifiers

PMID41061279
PMCPMC13035423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.